Singular Genomics Reports Key Update: 8-K Filing on February 19, 2025

Here are the key details extracted from the provided section of the financial report:

1. Company Information:

• Name: Singular Genomics Systems, Inc.
• CIK Number: 0001850906
• State of Incorporation: Delaware (DE)
• SEC File Number: 001-40443
• Employer Identification Number (EIN): 81-2948451
• Address: 3010 Science Park Road, San Diego, CA 92121
• Phone Number: (858) 333-7830

2. Filing Details:

• Filing Type: 8-K (a current report used to disclose important events)
• Filing Date: February 19, 2025

3. Stock Information:

• Common Stock Par Value: $0.0001 per share
• Trading Symbol: OMIC
• NASDAQ Listed: Yes

4. Period of Report:

• Start Date: February 19, 2025
• End Date: February 19, 2025

Insights:

• The filing is a Form 8-K, indicating that Singular Genomics Systems, Inc. has reported a significant event or change that investors should be aware of as of the date specified.
• The company is publicly traded on NASDAQ, which provides an avenue for investors to buy and sell its shares.
• The report is part of the XBRL (eXtensible Business Reporting Language) format, which is designed to facilitate the electronic sharing of financial data.

This summary provides a concise overview of the company and the nature of the filing, which is essential for investors or analysts reviewing the company's disclosures.